Litigation Details for VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)

VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)

Docket		Date Filed	2016-07-27
Court	District Court, D. New Jersey	Date Terminated	2017-01-09
Cause	28:1338 Patent Infringement	Assigned To	Katharine Sweeney Hayden
Jury Demand	None	Referred To	Cathy L. Waldor
Parties	HETERO USA, INC.; MITSUBISHI TANABE PHARMA CORPORATION
Patents	6,656,935; 7,501,409
Attorneys	CHARLES MICHAEL LIZZA; CHRISTINA LYNN SAVERIANO
Firms	Christina Lynn Saveriano; Eric I. Abraham
Link to Docket	External link to docket

Details for VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-07-27	1		United States Patent Nos. 6,656,935 (“the ’935 patent”) and 7,501,409 (“the ’409 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-In-Suit 17. On Dec. 2, 2003, the United States Patent and Trademark …the exclusive licensee of the ’935 patent. A copy of the ‘935 patent is attached hereto as Exhibit A. …the exclusive licensee of the ’409 patent. A copy of the ’409 patent is attached hereto as Exhibit B.	External link to document
2017-01-04	20		Filed 01/05/17 Page 4 of 5 Page|D: 196 Patent Nos. 6,656,935 and 7,501,409 and/or whether the product…claims of United States Patent Nos. 9,656,935 and 7,501,409 (“the Asserted Patents”) in connection with … the expiration of the Asserted Patents was a technical act of patent infringement with respect to one…Court has subject matter jurisdiction over this patent infringement action (the “Action”). The Court has… and Drug Administration (“FDA”). Asserted Patents are valid and enforceable in this Action. 4. For	External link to document